August 11, 2010 – New sizes of the SoloPath TransFemoral Endovascular Access Catheter were recently cleared by the U.S. Food and Drug Administration (FDA). The new sizes provide the potential to treat a larger patient population.
August 11, 2010 – More than 50 percent of cardiologists in a recent survey gave the health reform bill unsatisfactory marks, grading it as a D or an F. Only 1 percent of cardiologists graded it as an A and only 15 percent as a B.
August 11, 2010 – Based on its recent analysis of the computed tomography (CT) market, Frost & Sullivan recognizes Siemens Healthcare with the 2010 North American Frost & Sullivan Award for Technology Leadership of the Year.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 10, 2010 - A cardiovascular image reporting, consulting and training company in Brazil, entered into a multi-user 3Di software licensing contract with Shina Systems.
August 9, 2010 - Health care professionals will attend a conference devoted to the fundamentals of establishing and developing a cooling program and features Minneapolis physicians and other national experts, Miracle on Ice: Therapeutic Hypothermia for Cardiac Arrest Patients conference will take place September 9 to 10, in Minneapolis, Minn.
August 9, 2010 - Researchers at Mayo Clinic are working to reduce radiation dosages used to acquire perfusion and other CT images.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 9, 2010 – Enrollment was recently completed in a clinical trial of Medtronic’s Complete SE (self-expanding) vascular stent for the treatment of atherosclerosis in the superficial femoral artery (SFA), including the proximal popliteal artery (PPA).
August 9, 2010 – According to Millennium Research Group (MRG), a medical technology market research company, Invatec has traditionally held a much stronger position in the European percutaneous transluminal angioplasty (PTA) balloon catheter market compared to the United States.
August 9, 2010 – A merger is being finalized between Medtronic and cardiac surgery device maker ATS Medical. The company develops and manufactures products and services for the treatment of structural heart disease and the ablation of cardiac arrhythmias. ATS Medical expects the closing of the merger will take place on or about Aug. 12.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 4, 2010 — A second-generation of the Diamondback Predator 360 peripheral arterial disease (PAD) system features improvements in the crowns and shaft for enhanced clinical performance and shorter procedure times. The U.S. Food and Drug Administration (FDA) recently granted Cardiovascular Systems Inc. (CSI) special 510(k) marketing clearance for the device.
August 4, 2010 — When Beaumont Hospital physicians recently held a heart screening for high school students, they found some surprising results. Of the 402 students screened, 34 students were advised to continue with sports and follow-up with their personal physicians and an additional five students were instructed to stop exercise until fully evaluated.
August 4, 2010 — In recent years, concerns have been raised both inside and outside of the U.S. Food and Drug Administration (FDA) about whether the current 510(k) program achieves its goals of making safe and effective devices available to the public while fostering innovation.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
August 3, 2010 — Patient enrollment began in the EVOLVE clinical trial, which is designed to assess the safety and performance of the Boston Scientific Synergy Coronary Stent (previously referred to as the Evolution stent). It uses a bioabsorbable polymer and everolimus drug formulation to create a thin, uniform coating confined to the outer surface of the stent.
August 3, 2010 — Patients have the right to refuse or request the withdrawal of any unwanted medical treatment. In an article published in the online issue of Mayo Clinic Proceedings, investigators explore the legal and ethical permissibility of carrying out such a request specific to a ventricular assist device (VAD).
August 3, 2010 — St. Joseph’s Regional Medical Center (SJRMC) in Paterson, N.J., received the Chain of Survival Award from the Sudden Cardiac Arrest Association and accolades from New Jersey Gov. Chris Christie for its trendsetting work in using prehospital therapeutic cooling of cardiac arrest patients.